Adrienne L. Watson

992 citations

22 papers · 663 indexed · h-index 14

Co-authors: David A. Largaespada Nancy Ratner Eric P. Rahrmann Margaret H. Collins Vincent W. Keng Christopher L. Moertel Branden S. Moriarity Daniel F. Carlson
Topics: Neurofibromatosis and Schwannoma Cases (11 papers)Sarcoma Diagnosis and Treatment (10 papers)Neuroblastoma Research and Treatments (4 papers)
Cited by: Neurology Pulmonary and Respiratory Medicine Molecular Biology
Journals: Proceedings of the National Academy of Sciences Nature Genetics Bioinformatics
Partner nations: United States Hong Kong Spain

In The Last Decade

Adrienne L. Watson

21 papers receiving 652 citations

Peers

Countries citing papers authored by Adrienne L. Watson

Since Specialization

Citations

This map shows the geographic impact of Adrienne L. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrienne L. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrienne L. Watson more than expected).

Fields of papers citing papers by Adrienne L. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrienne L. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrienne L. Watson. The network helps show where Adrienne L. Watson may publish in the future.

Co-authorship network of co-authors of Adrienne L. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Adrienne L. Watson. A scholar is included among the top collaborators of Adrienne L. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrienne L. Watson. Adrienne L. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 6511: Immunocompetent large animal model of mesenchymal glioblastoma achieved through somatic gene editing technology 2025 ·Cancer Research ·(unknown),(unknown),Barbara R. Tschida,(unknown),Maryam Aftabizadeh,(unknown),Eric C. Holland,Massimo D’Apuzzo,Christine E. Brown,Adrienne L. Watson	0
2	Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1 2023 ·Molecular Therapy — Nucleic Acids ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Mark N. Kirstein,James Fisher,Christopher L. Moertel,Ming Du,David M. Bedwell,David A. Largaespada,Adrienne L. Watson	5
3	Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editing 2021 ·PLoS ONE ·Robert A. Kaiser,Daniel F. Carlson,(unknown),Dennis A. Webster,(unknown),Clara T. Nicolas,(unknown),Yue Yu,(unknown),(unknown),Raymond Hickey,Adrienne L. Watson,Shelley R. Winn,Beat Thöny,(unknown),Cary O. Harding,Joseph B. Lillegard	8
4	Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib 2021 ·Current Oncology Reports ·(unknown),Adrienne L. Watson,David A. Largaespada,Nancy Ratner,(unknown),Christopher L. Moertel	20
5	Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo 2021 ·Neuro-Oncology Advances ·(unknown),Alexander Coutts,(unknown),Barbara R. Tschida,Mark N. Kirstein,James Fisher,William R. Bell,Oona Delpuech,Paul D. Smith,Brigitte C. Widemann,Christopher L. Moertel,David A. Largaespada,Adrienne L. Watson	6
6	Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1 2021 ·International Journal of Molecular Sciences ·(unknown),Adrienne L. Watson,David A. Largaespada	11
7	Mammalian germ cells are determined after PGC colonization of the nascent gonad 2019 ·Proceedings of the National Academy of Sciences ·Peter K. Nicholls,Hubert Schorle,Sahin Naqvi,Yueh‐Chiang Hu,Yuting Fan,Michelle A. Carmell,Ina Dobrinski,Adrienne L. Watson,Daniel F. Carlson,Scott C. Fahrenkrug,David C. Page	79
8	Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomas 2019 ·Scientific Reports ·Susan K. Rathe,Flavia E. Popescu,James E. Johnson,Adrienne L. Watson,(unknown),Branden S. Moriarity,John R. Ohlfest,David A. Largaespada	31
9	Multiphoton fluorescence lifetime imaging of chemotherapy distribution in solid tumors 2017 ·Journal of Biomedical Optics ·Marjorie Carlson,Adrienne L. Watson,(unknown),David A. Largaespada,Paolo P. Provenzano	18
10	Engineered Swine Models of Cancer 2016 ·Frontiers in Genetics ·Adrienne L. Watson,Daniel F. Carlson,David A. Largaespada,Perry B. Hackett,Scott C. Fahrenkrug	47
11	Simple and Efficient Methods for Enrichment and Isolation of Endonuclease Modified Cells 2014 ·PLoS ONE ·Branden S. Moriarity,Eric P. Rahrmann,(unknown),Caitlin B. Conboy,Adrienne L. Watson,Daniel F. Carlson,Erik R. Olson,(unknown),Scott C. Fahrenkrug,R. Scott McIvor,David A. Largaespada	25
12	Trp53 Haploinsufficiency Modifies EGFR-Driven Peripheral Nerve Sheath Tumorigenesis 2014 ·American Journal Of Pathology ·Eric P. Rahrmann,Branden S. Moriarity,George M. Otto,Adrienne L. Watson,Kwangmin Choi,Margaret H. Collins,Margaret R. Wallace,Beau R. Webber,Colleen L. Forster,Anthony E. Rizzardi,Stephen C. Schmechel,Nancy Ratner,David A. Largaespada	27
13	Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity 2014 ·Oncotarget ·Adrienne L. Watson,(unknown),(unknown),Vincent W. Keng,Eric P. Rahrmann,(unknown),(unknown),Margaret H. Collins,Tilat A. Rizvi,Christopher L. Moertel,Nancy Ratner,David A. Largaespada	64
14	Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance 2013 ·Cancer Discovery ·Adrienne L. Watson,Eric P. Rahrmann,Branden S. Moriarity,Kwangmin Choi,Caitlin B. Conboy,(unknown),(unknown),(unknown),(unknown),Vincent W. Keng,Anthony E. Rizzardi,Colleen L. Forster,Margaret H. Collins,Aaron L. Sarver,Margaret R. Wallace,Stephen C. Schmechel,Nancy Ratner,David A. Largaespada	76
15	Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis 2013 ·Nature Genetics ·Eric P. Rahrmann,Adrienne L. Watson,Vincent W. Keng,Kwangmin Choi,Branden S. Moriarity,(unknown),Natalie K. Wolf,Aaron L. Sarver,Margaret H. Collins,Christopher L. Moertel,Margaret R. Wallace,Bernat Gel,Eduard Serra,Nancy Ratner,David A. Largaespada	108
16	Abstract 354: Conditional inactivation of Pten and overexpression of EGFR in Schwann cells results in early high-grade peripheral nerve sheath tumor development. 2013 ·Cancer Research ·Vincent W. Keng,Adrienne L. Watson,Eric P. Rahrmann,Hua Li,Barbara R. Tschida,Branden S. Moriarity,Kwangmin Choi,Tilat A. Rizvi,Margaret H. Collins,Margaret R. Wallace,Nancy Ratner,David A. Largaespada	2
17	PTEN and NF1 Inactivation in Schwann Cells Produces a Severe Phenotype in the Peripheral Nervous System That Promotes the Development and Malignant Progression of Peripheral Nerve Sheath Tumors 2012 ·Cancer Research ·Vincent W. Keng,Eric P. Rahrmann,Adrienne L. Watson,Barbara R. Tschida,Christopher L. Moertel,Walter J. Jessen,Tilat A. Rizvi,Margaret H. Collins,Nancy Ratner,David A. Largaespada	67
18	Diet and Energy-Sensing Inputs Affect TorC1-Mediated Axon Misrouting but Not TorC2-Directed Synapse Growth in a Drosophila Model of Tuberous Sclerosis 2012 ·PLoS ONE ·(unknown),(unknown),Adrienne L. Watson,(unknown),Hyun-Gwan Lee,Na Zhao,Michael B. O’Connor,Thomas P. Neufeld,Scott B. Selleck	16
19	Conditional Inactivation ofPtenwithEGFROverexpression in Schwann Cells Models Sporadic MPNST 2012 ·Sarcoma ·Vincent W. Keng,Adrienne L. Watson,Eric P. Rahrmann,Hua Li,Barbara R. Tschida,Branden S. Moriarity,Kwangmin Choi,Tilat A. Rizvi,Margaret H. Collins,Margaret R. Wallace,Nancy Ratner,David A. Largaespada	27
20	Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling 2010 ·Journal of Molecular and Cellular Cardiology ·Neeta Adhikari,David L. Basi,DeWayne Townsend,Melissa Rusch,Ami Mariash,Sureni V. Mullegama,Adrienne L. Watson,Jon D. Larson,Sara Tan,(unknown),Jeffrey D. Esko,Scott B. Selleck,Jennifer L. Hall	23

About Adrienne L. Watson

Adrienne L. Watson is a scholar working on Neurology, Structural Biology and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 663 indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (11 papers), Sarcoma Diagnosis and Treatment (10 papers) and Neuroblastoma Research and Treatments (4 papers). The work is most often cited by research in Neurology (247 citations), Pulmonary and Respiratory Medicine (160 citations) and Molecular Biology (310 citations). Adrienne L. Watson has collaborated with scholars based in United States, Hong Kong and Spain. Frequent co-authors include David A. Largaespada, Nancy Ratner, Eric P. Rahrmann, Margaret H. Collins, Vincent W. Keng, Christopher L. Moertel, Branden S. Moriarity, Daniel F. Carlson, Scott C. Fahrenkrug and Kwangmin Choi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact